June 14th 2020 – Cannabis plant may harbor SARS-CoV-2 for at least a week Researchers at the Medicinal Genomics Corporation have warned that cannabis flowers exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may harbor the virus for at least seven days.

April 6, 2020 – Cannabis and Coronavirus: Help Keeps Coming from Industry BusinessesMedicinal Genomics Corp. (MGC) has pledged proceeds from ticket sales for its CannMed 2020 tradeshow, will be donated to pandemic relief.

March 3, 2020 – Pharmaceutical company claims to have developed a cannabis treatment for coronavirus symptomsKevin McKernan, founder of Massachusetts-based life sciences company, Medicinal Genomics, tweeted, “Bummer. There is actually some exciting preliminary work on cannabinoids and viruses that are now getting sold before it’s (…) understood.”

January 29, 2020 – Arbor Biosciences, Biosearch Technologies Ink Global Distribution Deal for Ag-Bio NGS PanelsOver the last year, the firm has formed partnerships with Curio Genomics on bioinformatics for a wheat exome panel and with Medicinal Genomics for a cannabis genotyping panel.

December 11, 2019 – One man’s crusade to open-source cannabis DNAThe best way to circumvent future attempts to patent all or part of the plant’s DNA would be to create a genome map for a specific strain and put it in the public domain.

October 21, 2019 -3 Essential Components of Microbial Safety TestingMicrobial contamination on cannabis products represents one of the most significant threats to cannabis consumers, particularly immunocompromised patients who are at risk of developing harmful and potentially fatal infections.

September 11, 2019 – Collaboration to Advance Marker Discovery and Genotyping in Cannabis – MGC has identified the genetic variations that cause a plant to produce the important cannabinoids of THC, CBD, and their combinations, referred to as chemotypes (I-IV). This information provides a genetic fingerprint for different types and cultivars, and is a key to selective breeding of cannabis.

August 26, 2019 – How Phylos Bioscience sent shockwaves through the cannabis industry with ‘Big Ag’ disclosure – Cannabis growers and breeders are worried that genetics patents and data could be controlled by large corporate entities, which would limit genetic diversity and force smaller cannabis producers to pay more for seeds and clones.

May 30, 2019 – Game Of Genomes: The Battle For The King Of Cannabis Strains Is Just Heating Up A cannabis Ancestry.com

May 22, 2019 -VegaWallet and Covault Partner to Bring Dash Payments to Cannabis Dispensaries Then research firm Medicinal Genomics is using Dash to protect everyday cannabis growers from big pharma corporations attempting to patent cannabis plant genomes.